There are 2 papers on FZD3 in aging research: none in people yet, 1 in animals, 1 in cells.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 1 country
- Funder: Institute for Intelligent Healthcare, Tsinghua University
- Animals1
- Cells1
Upstream
2EP300
upin human cells1
1 study
EP300
upin human cells1
EP300 increases FZD3 in human cells (recruited by NEAT1; acts via histone acetylation).
“P300, an important histone acetyltransferases (HAT), recruited by NEAT1 to bind to FZD3 promoter and mediated its transcription via regulating histone acetylation.”
Cellsrecruited by NEAT1; acts via histone acetylation
Aging
NEAT1
upin human cells1
1 study
NEAT1
upin human cells1
NEAT1 increases FZD3 in human cells (shown by knockdown; acts via H3K27 acetylation at the FZD3 promoter).
“Downregulation of NEAT1 inhibited Frizzled Class Receptor 3 (FZD3) transcription activity by suppressing H3K27 acetylation (H3K27Ac) at the FZD3 promoter.”
Cellsshown by knockdown; acts via H3K27 acetylation at the FZD3 promoter
Aging
Latest
Aging Cell
Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells
Experiments in human cellsStem cell differentiation